UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - NYSE:UHS - US9139031002 - Common Stock
225.38 USD
-2.56 (-1.12%)
225.38 USD
0 (0%)
UHS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. UHS has an excellent profitability rating, but there are some minor concerns on its financial health. UHS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
UHS had positive earnings in the past year.
UHS had a positive operating cash flow in the past year.
UHS had positive earnings in each of the past 5 years.
Each year in the past 5 years UHS had a positive operating cash flow.
1.2 Ratios
UHS has a Return On Assets of 8.96%. This is amongst the best in the industry. UHS outperforms 94.00% of its industry peers.
The Return On Equity of UHS (19.18%) is better than 87.00% of its industry peers.
UHS's Return On Invested Capital of 12.33% is amongst the best of the industry. UHS outperforms 88.00% of its industry peers.
UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.38%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(12.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
The Profit Margin of UHS (8.09%) is better than 88.00% of its industry peers.
UHS's Profit Margin has been stable in the last couple of years.
UHS's Operating Margin of 11.47% is fine compared to the rest of the industry. UHS outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
UHS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UHS has been reduced compared to 5 years ago.
Compared to 1 year ago, UHS has an improved debt to assets ratio.
2.2 Solvency
UHS has a debt to FCF ratio of 4.84. This is a neutral value as UHS would need 4.84 years to pay back of all of its debts.
The Debt to FCF ratio of UHS (4.84) is better than 67.00% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio of 0.55. This is comparable to the rest of the industry: UHS outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | N/A |
ROIC/WACC1.46
WACC8.42%
2.3 Liquidity
UHS has a Current Ratio of 1.03. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
UHS's Current ratio of 1.03 is on the low side compared to the rest of the industry. UHS is outperformed by 72.00% of its industry peers.
A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
UHS has a worse Quick ratio (0.96) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.07% over the past year.
Measured over the past years, UHS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
Looking at the last year, UHS shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.53% yearly.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.84, the valuation of UHS can be described as reasonable.
89.00% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.07. UHS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.67, which indicates a very decent valuation of UHS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.08, UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.84 | ||
| Fwd PE | 9.67 |
4.2 Price Multiples
82.00% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
UHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UHS is cheaper than 74.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.81 | ||
| EV/EBITDA | 7.48 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
A more expensive valuation may be justified as UHS's earnings are expected to grow with 15.88% in the coming years.
PEG (NY)0.38
PEG (5Y)1.01
EPS Next 2Y18.34%
EPS Next 3Y15.88%
5. Dividend
5.1 Amount
UHS has a yearly dividend return of 0.35%, which is pretty low.
Compared to an average industry Dividend Yield of 2.57, UHS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, UHS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
UHS pays out 3.78% of its income as dividend. This is a sustainable payout ratio.
UHS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP3.78%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
225.38
-2.56 (-1.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.12%
Inst Owner Change-2.36%
Ins Owners5.45%
Ins Owner Change16.08%
Market Cap14.34B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts70.77
Price Target231.73 (2.82%)
Short Float %3.44%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)4.41%
PT rev (3m)2.74%
EPS NQ rev (1m)4.94%
EPS NQ rev (3m)4.66%
EPS NY rev (1m)3.24%
EPS NY rev (3m)7.7%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.84 | ||
| Fwd PE | 9.67 | ||
| P/S | 0.84 | ||
| P/FCF | 14.81 | ||
| P/OCF | 7.36 | ||
| P/B | 2 | ||
| P/tB | 4.51 | ||
| EV/EBITDA | 7.48 |
EPS(TTM)20.8
EY9.23%
EPS(NY)23.3
Fwd EY10.34%
FCF(TTM)15.21
FCFY6.75%
OCF(TTM)30.61
OCFY13.58%
SpS267.01
BVpS112.66
TBVpS49.97
PEG (NY)0.38
PEG (5Y)1.01
Graham Number229.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | N/A |
F-Score8
WACC8.42%
ROIC/WACC1.46
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
What is the valuation status for UHS stock?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for UHS stock?
The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 10.84 and the Price/Book (PB) ratio is 2.
Can you provide the financial health for UHS stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 4 / 10.